In the US, Trimethobenzamide (trimethobenzamide systemic) is a member of the drug class anticholinergic antiemetics and is used to treat Nausea/Vomiting.
US matches:
- Trimethobenzamide
- Trimethobenzamide Solution
- Trimethobenzamide/Benzocaine Suppositories
- Trimethobenzamide Intramuscular
- Trimethobenzamide Hydrochloride
Scheme
Rec.INN
CAS registry number (Chemical Abstracts Service)
0000138-56-7
Chemical Formula
C21-H28-N2-O5
Molecular Weight
388
Therapeutic Category
Antiemetic
Chemical Name
Benzamide, N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxy-
Foreign Names
- Trimethobenzamidum (Latin)
- Trimethobenzamid (German)
- Triméthobenzamide (French)
- Trimetobenzamida (Spanish)
Generic Names
- Trimetobenzamide (OS: DCIT)
- Trimethobenzamide Hydrochloride (PH: USP 32)
Brand Names
- Anti-Vomit
Deva, Turkey - Ametik Damla
Kurtsan, Turkey - Emedur
Sanofi-Aventis, Turkey - Tigan
JHP, United States; King, United States; Monarch, United States - Trimethobenzamide Hydrochloride
Actavis, United States; Amide, United States; Hospira, United States; Mutual, United States - Vomet
I.E. Ulagay, Turkey - Vomitin
Akdeniz, Turkey - Voselmit
Osel, Turkey
International Drug Name Search
Glossary
| DCIT | Denominazione Comune Italiana |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment